Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial

Autor: Joseph Bledsoe, Scott C. Woller, Maria Brooks, Frank C. Sciurba, Jerry A. Krishnan, Deborah Martin, Peter Hou, Janet Y. Lin, Andrei Kindzelski, Eileen Handberg, Bridget-Anne Kirwan, Elaine Zaharris, Lauren Castro, Nancy L. Shapiro, Carl J. Pepine, Sarah Majercik, Zhuxuan Fu, Yongqi Zhong, Vidya Venugopal, Yu-Hsuan Lai, Paul M. Ridker, Jean M. Connors

Publikováno v: BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-9 (2023)

Abstract Background Assessment for risks associated with acute stable COVID-19 is important to optimize clinical trial enrollment and target patients for scarce therapeutics. To assess whether healthcare system engagement location is an independent p

Externí odkaz: https://doaj.org/article/c3b73704cacf4ebf9f124b1a93adb25d

A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes

Autor: Mafauzy Mohamed, Roberto Luis Zagury, Kalpana Bhaskaran, Joel Neutel, Barakatun Nisak Mohd Yusof, Linda Mooney, Lihe Yeo, Bridget-Anne Kirwan, Olivier Aprikian, Maximilian von Eynatten, Odd Erik Johansen

Publikováno v: Diabetes Therapy. 14:749-766

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41857def5c027efe6dc406c4cc09a5d1
https://doi.org/10.1007/s13300-023-01379-4

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure

Autor: Marco, Metra, Ewa A, Jankowska, Matteo, Pagnesi, Stefan D, Anker, Javed, Butler, Fabio, Dorigotti, Vincent, Fabien, Gerasimos, Filippatos, Bridget-Anne, Kirwan, Iain C, Macdougall, Giuseppe, Rosano, Frank, Ruschitzka, Daniela, Tomasoni, Peter, van der Meer, Piotr, Ponikowski

Publikováno v: European Journal of Heart Failure, 24(10), 1928-1939. Wiley

Aims In AFFIRM-AHF, intravenous ferric carboxymaltose (FCM) reduced heart failure (HF) hospitalisations and improved quality of life versus placebo in iron-deficient patients stabilised after an acute HF episode. This analysis explored the effects of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55930696a6a3606483dc69887b9a2ef0
https://doi.org/10.1002/ejhf.2630

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure

Autor: Stefano Savonitto, D Soon, V Tseluyko, J Heymeriks, L Petrescu, Fabio T. M. Costa, P Garcia Pacho, G Chapidze, Michael Motro, M Diez, A Prado, Piotr Ponikowski, Sanjib Kumar Sharma, DL Serban, A. Salvioni, S del Prado, Giuseppe Boriani, Stephan von Haehling, HG Cestari, PR Nierop, LC Iosipescu, Hans Kragten, Má Hominal, Bridget-Anne Kirwan, Andre Keren, D Horvat, J Thierer, D Sim, Rabih R. Azar, Peter van der Meer, G Stanciulescu, F Cosmi, Sy Loh, Jarosław Drożdż, David Sim, K Paposhvili, M Berli, Alain Cohen-Solal, Stefan D. Anker, Arnaout, ML Parody, GO Zapata, T Ben-Gal, J Schaap, Bas L.J.H. Kietselaer, O Raed, G Kiwan, Marco Metra, Shaul Atar, Udo Michael Göhring, Edoardo Gronda, A Ružić, C Beltrano, Dpw Beelen, Davor Milicic, R Ray, JM Weinstein, FI Ga Bosa Ojeda, Y-K Wong, Dalton Bertolim Précoma, Javed Butler, JR Gonzalez Juanatey, V Chumburidze, Gerasimos Filippatos, V Witzling, Y Malynovsky, I Kraiz, A Samodol, J Trevelyan, L Nigro Maia, M Stanislavchuk, Gilmar Reis, I Khintibidze, D Zdrenghea, Beata Wożakowska-Kapłon, BD Molina, C Abdallah, Ham van Kesteren, Tim Friede, Marcin Gruchała, Majdi Halabi, Ewa A. Jankowska, P Van Bergen, Constantin Militaru, O Koval, DA Darabantiu, A Kormann, J Szachniewicz, Maria Dorobantu, M van de Wetering, R Nijmeijer, H Hamdan, Stefano Ghio, Henry J. Dargie, G Azize, Nicolas Danchin, S Chaaban, S Gerward, P Pimentel Filho, M Uguccioni, K Abdelbaki, N Vita, J.F.K. Saraiva, D Almeida, Michael Shochat, M Ohlsson, R Van de Wal, V Zolotaikina, W Kinany, A Tycińska, A Hershson, T Shaburishvili, Vincent Fabien, FR dos Santos, Alfredo Bardají, Rgej Groutars, M Flugelman, J Bono, M Udovicic, M Artuković, K Šutalo, J Drozdz, TJ Yeo, F Ferre Pacora, Z Lominadze, M Emans, S Pettit, HA Luquez, P Terrosu, Marcus Ohlsson, M Gąsior, S Tušek, Enrico Passamonti, Nyy Al-Windy, P Midi, DA Pascual Figal, P van der Meer, V Zvi, Wilco Tanis, Felipe Martinez, RR Borelli, Diana A. Gorog, O Parhomenko, Klaus H Jensen, M Meijs, J Nessler, M Piepoli, DM Toader, Jose C. Nicolau, A Glenny, José Luis Zamorano, L Tilling, T McDonagh, K Pesek, H Fernandez, Davor Miličić, Domingo A. Pascual-Figal, Theresa McDonagh, G Khabeishvili, Josep Comin-Colet, Israel Gotsman, S Rassi, M Dorobantu, E Straburzyńska-Migaj, L Fattore, L Rudenko, D Crisu, S.S. Kabbani, M Gomez Bueno, Basil S. Lewis, S Goland, Y Arbel, M Bronisz, I Vakaliuk, A Fucili, A Mortara, R Zukermann, N Emukhvari, B Hassouna, K Mizia-Stec, F Turrini, R Szelemej, A Rodica Dan, L Lobo Marquez, Hadi Skouri, A Kabir, Frank Ruschitzka, R García Durán, R Gil, Michael Shechter, P Westendorp, Piergiuseppe Agostoni, A Fernandez, Oscar Pereira Dutra, P Ameri, Wolfram Doehner, JG Smith, Irakli Khintibidze, Luciano Moreira Baracioli, J Šikić, Stuart Pocock, Olivier C. Manintveld, MC Tomescu, M Di Biase, Luiz Carlos Bodanese, E Mirek-Bryniarska, Alexander Parkhomenko

Publikováno v: LANCET, 396(10266), 1895-1904. ELSEVIER SCIENCE INC
The Lancet
The Lancet, 396(10266), 1895-1904. Elsevier Ltd.
The Lancet, 2020, 396 (10266), pp.1895-1904. ⟨10.1016/S0140-6736(20)32339-4⟩

Background: Intravenous ferric carboxymaltose has been shown to improve symptoms and quality of life in patients with chronic heart failure and iron deficiency. We aimed to evaluate the effect of ferric carboxymaltose, compared with placebo, on outco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::221bf735e50009e83726ce7dc2a55d76
https://pure.eur.nl/en/publications/a4645943-8e64-44a3-b558-003d858b21f5

Efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency with and without anaemia: a subgroup analysis of AFFIRM-AHF

Autor: Javed Butler, P van der Meer, Iain C. Macdougall, Sandra Waechter, Ewa A. Jankowska, Dimitrios Farmakis, Gerasimos Filippatos, Frank Ruschitzka, M. Metra, Bridget-Anne Kirwan, Vincent Fabien, Piotr Ponikowski, Stefan D. Anker

Publikováno v: Web of Science

Background Iron deficiency is associated with increased morbidity and mortality in patients with acute heart failure (HF), even in the absence of anaemia. Purpose This prespecified subanalysis of the AFFIRM-AHF trial investigated the effects of ferri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc92e2ee97df92d52aaf27dc12519ad4
https://doi.org/10.1093/eurheartj/ehab724.1053